NRx Pharmaceuticals Statistics
Total Valuation
NRXP has a market cap or net worth of $97.12 million. The enterprise value is $89.96 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NRXP has 33.03 million shares outstanding. The number of shares has increased by 101.06% in one year.
| Current Share Class | 33.03M |
| Shares Outstanding | 33.03M |
| Shares Change (YoY) | +101.06% |
| Shares Change (QoQ) | +30.27% |
| Owned by Insiders (%) | 5.40% |
| Owned by Institutions (%) | 6.71% |
| Float | 24.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1.81 |
| PS Ratio | 79.28 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 73.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.31
| Current Ratio | 0.31 |
| Quick Ratio | 0.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -121.85% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 103.62% |
| Weighted Average Cost of Capital (WACC) | 14.77% |
| Revenue Per Employee | $42,241 |
| Profits Per Employee | -$986,966 |
| Employee Count | 29 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.49% in the last 52 weeks. The beta is 1.83, so NRXP's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | +48.49% |
| 50-Day Moving Average | 2.11 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 66.59 |
| Average Volume (20 Days) | 1,030,063 |
Short Selling Information
The latest short interest is 2.51 million, so 7.60% of the outstanding shares have been sold short.
| Short Interest | 2.51M |
| Short Previous Month | 2.75M |
| Short % of Shares Out | 7.60% |
| Short % of Float | 10.36% |
| Short Ratio (days to cover) | 3.01 |
Income Statement
In the last 12 months, NRXP had revenue of $1.23 million and -$28.62 million in losses. Loss per share was -$1.34.
| Revenue | 1.23M |
| Gross Profit | 720,000 |
| Operating Income | -16.19M |
| Pretax Income | -28.62M |
| Net Income | -28.62M |
| EBITDA | -16.12M |
| EBIT | -16.19M |
| Loss Per Share | -$1.34 |
Full Income StatementBalance Sheet
The company has $7.80 million in cash and $631,000 in debt, with a net cash position of $7.17 million or $0.22 per share.
| Cash & Cash Equivalents | 7.80M |
| Total Debt | 631,000 |
| Net Cash | 7.17M |
| Net Cash Per Share | $0.22 |
| Equity (Book Value) | -15.94M |
| Book Value Per Share | -0.50 |
| Working Capital | -19.69M |
Full Balance SheetCash Flow
| Operating Cash Flow | -14.11M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 70,000 |
| Net Borrowing | 4.68M |
| Free Cash Flow | -14.11M |
| FCF Per Share | -$0.43 |
Full Cash Flow StatementMargins
| Gross Margin | 58.78% |
| Operating Margin | -1,321.47% |
| Pretax Margin | -2,336.49% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NRXP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -101.06% |
| Shareholder Yield | -101.06% |
| Earnings Yield | -29.47% |
| FCF Yield | -14.53% |
Analyst Forecast
The average price target for NRXP is $38.00, which is 1,192.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.00 |
| Price Target Difference | 1,192.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 162.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 2, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Apr 2, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
NRXP has an Altman Z-Score of -37.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -37.88 |
| Piotroski F-Score | 2 |
